Comparing Ajovy vs Emgality
| Ajovy Remove Ajovy from your drug comparison | Emgality Remove Emgality from your drug comparison |
|
|---|
| Ajovy fremanezumab Remove Ajovy from your drug comparison | Emgality galcanezumab Remove Emgality from your drug comparison |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ajovy is a prescription medicine used to prevent migraine headaches that can be self-injected under the skin once a month or once every three months (using a higher dosage). Injection site reactions... View more |
Emgality is an injectable medication that can be self-administered subcutaneously (under the skin) once monthly for the prevention of migraine in adults or during a cluster headache period when used... View more |
||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
|||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
|
See the full Ajovy side effects document. |
See the full Emgality side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Ajovy prices |
View all Emgality prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
|
No |
No |
||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
|
744 hours |
648 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
|
Summary unavailable. See the full Pregnancy Warnings document. |
Summary unavailable. See the full Pregnancy Warnings document. |
||||||||||||||||
Drug Interactions |
|||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
|||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
First Approval Date |
|||||||||||||||||
|
September 14, 2018 |
September 27, 2018 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Patient resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.